Company Overview and News

1
Can Progressive (PGR) Retain Earnings Beat Streak in Q2?

2018-07-13 zacks
The Progressive Corporation (PGR - Free Report) is slated to report second-quarter 2018 results on Jul 17 before the market opens. Last reported quarter, the company delivered a positive surprise of 2.60%. Factors to be Considered in Q2 The top line is likely to have witnessed improvement in the to-be-reported quarter, driven by an expected increase in premiums, investment income coupled with higher service revenues and fees as well as other revenues.
TRV AXS.PRE AXS.PRC PGR AXS AXS.PRD CB

1
7 Insurers Poised to Outperform in Q2 on Many Tailwinds

2018-07-12 zacks
The Finance sector is set to kick off its earnings season this week with major banks reporting quarterly results. Improving rate environment and tax cuts should continue to drive the sector’s performance. Per the Earnings Outlook, earnings for the sector are expected to increase 18.5% on 3.6% higher revenues. Insurers, an important component of the Finance sector, are shortly going to release their financial numbers.
UNM TMK TRV SLF PGR TMK CNO SLF ALL MFC MFC CB

0
United Fire Looks A Little Overheated In A Still-Challenging Sector

2018-07-06 seekingalpha
United Fire's results have been pressured by soft renewal rates and an upswing in accident-year loss ratios.
CB

6
Near-Term Trends Masking The Long-Term Potential For ProAssurance

2018-07-06 seekingalpha
ProAssurance is looking at worsening claims severity in medical liability insurance, but it is better-reserved than most and the market seems to be starting to harden.
BRK.A CNA AIG CB PRA

2
In A Tougher Market, W.R. Berkley Has Outperformed

2018-07-04 seekingalpha
W.R. Berkley has seen decent overall pricing in its insurance operations, and underwriting profitability has remained strong, augmented by very good investment performance.
AFW TRV AFGE AFA AFGH ACGL HIG.WS EIG AFG WRB HIG ARH.PRC ARHPF HGH CB

16
Arch Capital Sticking To Its Guns, But The Street Is Unimpressed

2018-07-03 seekingalpha
Once again Arch Capital makes its case to the Street about why mortgage insurance is a good business, and once again the Street yawns and says "well, I don't know."
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC CB FMCCS FMCCT

16
Arch Capital Sticking To Its Guns, But The Street's Unimpressed

2018-07-03 seekingalpha
Once again Arch Capital makes its case to the Street about why mortgage insurance is a good business, and once again the Street yawns and says "well, I don't know."
FMCCO FMCCP FMCCM FMCCN FMCCI FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL FMCKI FMCKJ FMCC CB FMCCS FMCCT

40
Dividend Champions List For June 2018

2018-07-02 seekingalpha
As many of you know, the untimely death of David Fish left a void in many of us. His creation, the list of Dividend Champions, Contenders and Challengers provided an indispensable amount of information for dividend growth investors. It is unclear who will inherit those responsibilities. This was the best list for dividend investors, with a comprehensive number of companies and a wealth of data for further analysis.
HP CB

152
Chubb Limited: Buy This Dividend Aristocrat For Steady Increasing Income

2018-06-29 seekingalpha
Chubb Limited has increased its dividend for at least 25 years in a row with a present yield of 2.3% above average with a moderate dividend growth rate.
DLR.PRH HD DLR.PRG DLR.PRJ DLR.PRI ADP ADPVV JNJ DLR EOS BA CB DLR.PRC DLR.PRF

39
Hartford Undervalued And Improving In A Sector That Seems Adrift

2018-06-28 seekingalpha
P&C rates have improved some, and Hartford has flexed its muscle a bit in its personal lines, while underlying underwriting profitability has started to improve.
CB

39
Argo's Top-Line Growth Is Exciting, But ROEs Remain Lackluster

2018-06-27 seekingalpha
Argo's efforts to build out an automated quoting platform and expand into new programs appear to be driving strong premium growth across the business.
WRB ARGO CB

50
Dividend Stock Analysis: Cincinnati Financial Corporation

2018-06-20 seekingalpha
This weekend, with a nice cup of coffee in hand, I started performing research to identify a new undervalued dividend growth stock to add to my portfolio. When I was using my stock screener, I noticed that there was one Dividend Aristocrat that was currently down 7.98% year-to-date. Obviously, that caught my attention. I thought it would be a great idea to perform a dividend stock analysis to determine if this company was currently undervalued and would pass the metrics of our Dividend Stock Screener.
TRV CINF CB

117
Top Analyst Upgrades and Downgrades: BlackRock, Chevron, Disney, Intel, Kinder Morgan, Zillow and More

2018-06-18 247wallst
The futures traded lower again Monday morning as we look to see some follow-through selling in the wake of the announcement on the tariffs starting on some overseas products in early July. Investors should be heartened by the outstanding economic news that continues to pour in, and with only two weeks left in the second quarter, it’s a solid bet that earnings will be very positive.
RF.PRB RF.PRA DB KMI.WS INPAP RF BLK IP KMI.PRA KMI CVX GPN TRI CB INTC KMR CVB KMRFZ DIS

41
Here's Why You Should Retain Chubb (CB) in Your Portfolio

2018-06-11 zacks
Estimates for Chubb Limited (CB - Free Report) have been revised upward over the past 60 days, reflecting analysts’ confidence in the stock. The stock has seen the Zacks Consensus Estimate for 2018 and 2019 earnings being raised 1.7% and 0.8% to $10.42 and $11.21, respectively. Chubb is one of the world’s largest providers of property and casualty insurance and reinsurance, providing specialized insurance products such as personal accident, supplemental health and life insurance.
CB CVS RLI Y MKL

55
Weekly Edge: U.S. Companies Begin Preparations To Exit Iran

2018-06-06 seekingalpha
Companies in the United States are beginning to scale down their business with Iran as sanctions begin to tighten for the second-richest country in the Middle East.
HON GE GEC HON GNE CB

Related Articles

CYTX: Cytori Therapeutics Analysis and Research Report

1h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

Silicon Investor Message Boards

This table lists all message boards related to CB / Chubb Ltd on message board site Silicon Investor.

Anything graphite based, CCB, Zen and hopefully much more. CCB vs ZEN truth board
Canada Carbon CCB-V ZEN vs CCB
CB Richard Ellis Group, Inc. CBIS.OB Cannabis Science
CCB Free Speech Board Northstar Electronic: NEIK-OTCBB
CRAiLAR Technologies Inc. (OTCBB: CRLRF TSX: CL) Chicago Bridge u0026 Iron Company N.V. (CBI)
CUSIP: H1467J104